Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Blood Advances|June 3, 2018
A potent tetravalent T-cell-engaging bispecific antibody against CD33 in acute myeloid leukemiaSayed Shahabuddin Hoseini, Hongfen Guo, Zhihao Wu, et al.
Oncoimmunology|July 7, 2017
Bispecific antibody does not induce T-cell death mediated by chimeric antigen receptor against disialoganglioside GD2Sayed Shahabuddin Hoseini, Konstantin Dobrenkov, Dmitry Pankov, et al.
Acta Medica Iranica|August 30, 2012
Sleep-related eating disorder: a case report of a progressed night eating syndromeSaeed Shoar, Mohammad Naderan, Nasrin Shoar, et al.
Blood Advances|September 18, 2024
Targeting T cells with tetravalent bispecific antibodies for the treatment of graft-versus-host diseaseMadelyn Espinosa-Cotton, Sayed Shahabuddin Hoseini, Ileana C Miranda, et al.
Pediatric Blood & Cancer|April 12, 2021
Potent antitumor effect of T cells armed with anti-GD2 bispecific antibodyMiho Nakajima, Hong-Fen Guo, Sayed Shahabuddin Hoseini, et al.
Acta Medica Iranica|July 28, 2012
Cerebral sinovenous thrombosis (CSVT) in a neonate with different manifestationsSaeed Shoar, Nasrin Shoar, Nima Rezaei, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|December 18, 2016
Bariatric surgery in morbidly obese patients with inflammatory bowel disease: A systematic reviewSaeed Shoar, Sayed Shahabuddin Hoseini, Mohammad Naderan, et al.
Annals of Translational Medicine|April 4, 2018
Variable selection in Logistic regression model with genetic algorithmZhongheng Zhang, Victor Trevino, Sayed Shahabuddin Hoseini, et al.
Journal of Hematology & Oncology|April 22, 2024
Heterodimerization of T cell engaging bispecific antibodies to enhance specificity against pancreatic ductal adenocarcinomaAlan W Long, Hong Xu, Brian H Santich, et al.
Journal for Immunotherapy of Cancer|May 26, 2021
T cell engaging bispecific antibodies targeting CD33 IgV and IgC domains for the treatment of acute myeloid leukemiaSayed Shahabuddin Hoseini, Mallika Vadlamudi, Madelyn Espinosa-Cotton, et al.
Pageof 2